project id: TCGA-LUAD; case submitter id: TCGA-44-2664; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 66; days to birth: -24468; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1943; age at diagnosis: 24468; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1251.0; icd 10 code: C34.3; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower lobe, lung; synchronous malignancy: No; tissue or organ of origin: Lower lobe, lung; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Not Reported; cigarettes per day: 1.2602739726027397; pack years smoked: 23.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.6; longest dimension: 1.0; oct embedded: No; shortest dimension: 0.4; portion submitter id: TCGA-44-2664-01A-01; percent lymphocyte infiltration: 15.0; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 70.0;